Latest News

Alzheimer's Disease Research

A new study bridging neuroscience and machine learning offers insights into the potential role of astrocytes in the human brain. 

Aug 16, 2023
Macular Degeneration Research

Izervay, a second drug to treat the advanced and severe form of dry macular degeneration known as geographic atrophy, has received full FDA approval, opening another avenue of hope for people with this vision-stealing condition.

Aug 8, 2023
National Glaucoma Research

Harnessing the power of artificial intelligence, researchers have identified nearly 200 previously unknown DNA regions linked to a risk of developing glaucoma, findings that could lead to new ways of preventing the disease. 

Aug 3, 2023
Alzheimer's Disease Research

A BrightFocus-funded team has identified a potential way to diagnose a rare but devastating form of early Alzheimer’s disease by examining cells of the inner eye.

Aug 3, 2023
Alzheimer's Disease Research

Global nonprofit BrightFocus Foundation is pleased to announce that it has received a $50,000 donation from Alzheimer’s Los Angeles (Alzheimer’s LA) to support two innovative Alzheimer’s disease research scientists as part of the Foundation’s 2023 research portfolio.

Aug 1, 2023
Macular Degeneration Research

For the first time, a research team has created laboratory-grown cone photoreceptor cells that respond to light, unlocking a potential new way to treat macular degeneration. 

Jul 31, 2023
Research News

Research awarded by BrightFocus totals nearly $290 million to date across 25 countries, enabling innovative scientists from around the world to push the boundaries of Alzheimer’s, macular degeneration, and glaucoma research.

Jul 25, 2023
Alzheimer's Disease Research

Donanemab, a potential new amyloid-clearing Alzheimer’s drug, has been shown to slow cognitive decline by 35% in the early stages of Alzheimer’s disease. 

Jul 20, 2023
Alzheimer's Disease Research

Blacks and Hispanics with neuropsychiatric symptoms are more likely to develop cognitive impairment, according to recent BrightFocus-funded research.

Jul 10, 2023
Macular Degeneration Research

A BrightFocus-funded research team has identified how an FDA-approved antioxidant may be used to help prevent age-related macular degeneration in people with certain genetic risk factors for the disease. 

Jul 10, 2023